GlassScriptPhysician profile
Amber Leigh Contillo
NPI 1154630838
$1,684.07
in general payments reported to CMS, 2019-2025
17 companies · $356 in 2025
The $356 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $120 · 2022: $207 · 2023: $292 · 2024: $708 · 2025: $356.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,357.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,356.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $457.75 | 2022-2025 | |
| Neurelis, INC. | $245.63 | 2023-2025 | Valtoco |
| Ucb, INC. | $219.79 | 2022-2025 | Briviact, Fintepla |
| Immedica Pharma US, INC. | $134.59 | 2023-2024 | |
| Catalyst Pharmaceuticals, INC. | $113.65 | 2023-2024 | Fycompa |
| Eisai INC. | $81.65 | 2021-2022 | |
| Sk Life Science, INC. | $79.94 | 2021-2024 | |
| Acadia Pharmaceuticals INC | $72.11 | 2023-2025 | Daybue |
| Upsher-Smith Laboratories LLC | $69.91 | 2023-2025 | |
| Pyros Pharmaceuticals, INC. | $53.60 | 2024 | Vigpoder |
| Azurity Pharmaceuticals, INC. | $42.25 | 2022-2023 | Eprontia |
| Ns Pharma, INC. | $23.11 | 2023 | Viltepso |
| Biocodex, INC. | $20.85 | 2025 | |
| Sunovion Pharmaceuticals INC. | $19.30 | 2021 | |
| Aquestive Therapeutics, INC. | $18.82 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aucta Pharmaceuticals, INC. | $16.60 | 2025 | Motpoly Xr |
| Biomarin Pharmaceutical INC. | $14.52 | 2023 | Brineura |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amber Contillo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.